This week we look at infant screen time and anxiety, global pain levels, d-dimer and DVT, and tertiary patents on FDA approved drugs.

This week's topics include managing back pain, private equity and IVF clinics, EKGs and chronic liver disease, and lay health workers and older adults with cancer.

This week's topics include using how long someone smokes to determine screening, use of an antiviral in people with Alzheimer's, outcomes of lung cancer screening, and the real story about saturated fats in our diets.

This week's topics include covid vaccination and pregnancy outcomes, tirzepatide benefits, bisphosphonates and complex pain syndrome, and breast density knowledge.

This week's topics include pain and functioning, delivery to prevent preeclampsia, AI informing stroke treatment, and how effective is rotator cuff surgery.

This week's topics include corticosteroids in pregnancy, WHO guidance on GLP-1s, tai chi for chronic insomnia, and flu, RSV and COVID-19 vaccine updates.

This week's topics include decentralized clinical trials, GLP-1 peripregnancy, LLM and normal tissue characterization, and texting to improve CVD risk assessment.

This week's topics include acetaminophen in pregnancy and ASD, the impact of canceling fudning for clinical trials, supplementing potassium in people with ICDs, and mRNA flu vaccines.

This week's topics include medications after successful ablation for afib, fish oil for those having hemodialysis, anticoagulation after stent placement, and best therapy for stents and afib.

This week's topics include an oral medication for obesity, stem cells after MI and heart failure, blood markers and MS, and beyond BMI for atherosclerosis.

This week's topics include AI and diabetes prevention, best exercise for knee OA, the Mediterranean diet and IBS, and stepping characteristics for CVD health.

This week's topics include benefits of nicotine reduction in cigarettes, new onset afib after heart surgery, brain structure in infants after maternal PFAS exposure, and food insecurity and blood pressure.

This week's topics include impact of social media on adolescent cognition, gene therapy for ADA deficiency, a new treatment for SLE, and AI in health care.  

This week's topics include a look at obesity medicines in adults, aldosterone and CVD risk, environmental impact of inhalers, and where U.S. antibiotics are originating.

This week's topics include an RSV antibody for healthy infants, cancer risk and CT in early life, treating pulmonary hypertension early, and medicines for bronchiectasis. 

This week's topics include alcohol and dementia, treating type 1 diabetes, outcomes when private equity takes over hospitals, and aspirin in CRC.

This week's topics include risk of second cancers after a first breast cancer, stalking and CVD, number of mental health disorders and dementia, and lipoprotein(a) and widespread vascular disease.

This week's topics include LSD and anxiety disorders, cardiac rehab in older people after MI, CT and pregnancy outcomes, and a new agent for treatment of resistant hypertension.

This week's topics include use of beta blockers after MI, revascularization in NSTEMI, discontinuation of blood thinners after ablation for afib, and use of RSV vaccination and hospitalization and other outcomes. Program notes: 0:53 Who needs a beta blocker after MI 1:53 Those with mild reduction of ejection fraction 2:53 Confined to those with 40-50% ejection fraction 3:15 Revascularization in NSTEMI 4:20 Composite outcome 5:20 Closes gap, do FFR 6:20 May not be physiologically significant 6:40 Is lifelong anticoagulation needed after ablation 7:41 Occurred less in those who stopped 8:30 RSV, cardiac events and hospitalizations 9:30 Lower hospitalization in those who got the vaccine 10:30 Acute respiratory illness hospitalization 11:30 Less benefit with existing CVD or immunocompromise 12:15 Several RSV vaccines 13:16 End

This week's topics include trauma predictive brain networks, AI and colonoscopy, ADHD treatment and behavior choices, and medication affordability around the world. Program notes: 0:44 Drug prices around the world 1:41 German prices as standard 2:40 Wide variation in price and affordability 3:40 Generic pricing 4:20 ADHD meds and behavior choices 5:20 Largely treated with methylphenidate 6:20 Significantly impacted suicidality and other behaviors 6:49 AI assistance and colonoscopy skills 7:49 When you stop AI assistance 8:50 Does this apply to other procedures that use AI 9:20 Trauma predictive brain networks 10:20 Use of hydrocortisone to damp down 11:20 Previous trauma impact 12:25 Developmental timing 13:30 End